PME 2.24% $141.09 pro medicus limited

Ann: Change of Director's Interest Notice, page-36

  1. 13,068 Posts.
    lightbulb Created with Sketch. 1055
    Sorry to be somewhat late in replying but as a former long term holder of this quality stock run by quality management may I offer some points;

    PME has always traded outside the bounds of what is typically textbook metrics applied to quality companies and, investors have been happy to pay the appropriate share price - albeit at what some may perceive as being a premium. Indeed most industry commentators over the years have referred to the company as being a gold class investment.

    For instance, only last year, in April 2021 their valuation increased by $1.4B to $7.3B and this year the price has suffered as a result of global inflation.

    Finally, adding in a weekly chart I would be content to suggest that it could potentially bounce from this level.


    https://hotcopper.com.au/data/attachments/4377/4377564-ff1924f42a85fc9cb424c08067f57f77.jpg

 
watchlist Created with Sketch. Add PME (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.